IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

CHI Advisors LLC

Q2 2022 Holdings

Filed 2022-08-12 | 28 holdings | $49.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cullinan Oncology Inc(CGEM)COM230031106$39.1M3,047,60979.8%
Compass Therapeutics Inc(CMPX)COM20454B104$7.5M2,829,71215.3%
Corvus Pharmaceuticals Inc(CRVS)COM221015100$2.2M2,214,1844.5%
Prometheus Biosciences IncCOM74349U108$47.2K1,671,9760.1%
Repare Therapeutics Inc(RPTX)COM760273102$37.0K2,646,7810.1%
Pliant Therapeutics Inc(PLRX)COM729139105$24.9K3,106,8070.1%
Vectivbio Hldg AGORD SHSH9060V101$20.4K3,782,1990.0%
Kezar Life Sciences IncCOM49372L100$15.2K1,840,7930.0%
2Seventy BIO Inc(TSVT*)COMMON STOCK901384107$10.8K819,6720.0%
Inozyme Pharma IncCOM45790W108$9.7K2,033,8020.0%
Ikena Oncology IncCOM45175G108$4.8K1,090,9370.0%
Precision Biosciences IncCOM74019P108$4.8K3,003,7510.0%
Nkarta Inc(NKTX)COM65487U108$4.4K358,0130.0%
Freeline Therapeutics HldgsSPONSORED ADS35655L107$4.2K4,862,3190.0%
Omega Therapeutics IncCOMMON STOCK68217N105$4.0K1,055,8820.0%
Akouos IncCOM00973J101$3.9K836,1200.0%
G1 Therapeutics Inc(GTHXEUR)COM3621LQ109$3.8K767,2350.0%
Orchard Therapeutics PLCADS68570P101$3.1K5,307,7510.0%
Oncorus IncCOM68236R103$3.0K2,367,4360.0%
Larimar Therapeutics Inc(LRMR)COM517125100$3.0K1,515,1480.0%
Keros Therapeutics Inc(KROS)COM492327101$2.9K103,4290.0%
Entrada Therapeutics Inc(TRDA)COM29384C108$2.0K163,4960.0%
Ovid Therapeutics Inc(OVID)COM690469101$1.9K864,8220.0%
Eiger Biopharmaceuticals Inc(CLDNEUR)COM28249U105$1.2K190,0000.0%
Phasebio Pharmaceuticals IncCOM717224109$450750,0000.0%
Spdr SER TR(XBI)PutS&P BIOTECH78464A870$372157,0000.0%
Kezar Life Sciences IncCallCOM49372L100$5100,0000.0%
Eiger Biopharmaceuticals Inc(CLDNEUR)CallCOM28249U105$425,1000.0%